Literature DB >> 3312023

Pharmacokinetics of antibiotics in cystic fibrosis patients with particular reference to the bronchopulmonary tree (review).

E Bergogne-Berezin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3312023     DOI： 10.1007/BF01644140

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  19 in total

1.  The role of antibiotics given by inhalation in chronic chest disease.

Authors:  D Maxwell
Journal:  J Antimicrob Chemother       Date:  1983-03       Impact factor: 5.790

2.  Pharmacokinetics of apalcillin in intensive-care patients: study of penetration into the respiratory tract.

Authors:  E Bergogne-Berezin; J Pierre; J Chastre; C Gibert; G Heinzel; J P Akbaraly
Journal:  J Antimicrob Chemother       Date:  1984-07       Impact factor: 5.790

Review 3.  Penetration of antibiotics into respiratory secretions.

Authors:  J E Pennington
Journal:  Rev Infect Dis       Date:  1981 Jan-Feb

4.  Carbenicillin and gentamicin: pharmacologic studies in patients with cystic fibrosis and pseudomonas pulmonary infections.

Authors:  M I Marks; R Prentice; R Swarson; E K Cotton; T C Eickhoff
Journal:  J Pediatr       Date:  1971-11       Impact factor: 4.406

5.  Some observations on the penetration of antibiotics through mucus in vitro.

Authors:  B A Saggers; D Lawson
Journal:  J Clin Pathol       Date:  1966-07       Impact factor: 3.411

6.  Single-dose pharmacokinetics of cefsulodin in patients with cystic fibrosis.

Authors:  M D Reed; R C Stern; T S Yamashita; I Ackers; C M Myers; J L Blumer
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

7.  Ceftazidime in treatment of acute pulmonary exacerbations in patients with cystic fibrosis.

Authors:  R Padoan; A Brienza; R M Crossignani; G Lodi; A Giunta; B M Assael; F Granata; E Passarella; P A Vallaperta; L Xerri
Journal:  J Pediatr       Date:  1983-08       Impact factor: 4.406

8.  Azlocillin and gentamicin in respiratory tract infections with Pseudomonas aeruginosa in patients with cystic fibrosis.

Authors:  A S Malmborg; H Alfredsson; E Kusoffsky; B Strandvik
Journal:  Scand J Infect Dis Suppl       Date:  1981

9.  Azlocillin with and without an aminoglycoside against respiratory tract infections in children with cystic fibrosis.

Authors:  H Michalsen; T Bergan
Journal:  Scand J Infect Dis Suppl       Date:  1981

10.  Antibiotic treatment of chronic Pseudomonas aeruginosa infection in cystic fibrosis patients.

Authors:  N E Møller; N Høiby
Journal:  Scand J Infect Dis Suppl       Date:  1981
View more
  5 in total

1.  Treatment of infections in patients with cystic fibrosis.

Authors:  M I Marks
Journal:  Infection       Date:  1987       Impact factor: 3.553

Review 2.  High dose treatment with antibiotics in cystic fibrosis--a reappraisal with special reference to the pharmacokinetics of beta-lactams and new fluoroquinolones in adult CF-patients.

Authors:  F Sörgel; U Stephan; H G Wiesemann; B Gottschalk; C Stehr; M Rey; H B Böwing; H C Dominick; M Geldmacher von Mallinckrodt
Journal:  Infection       Date:  1987       Impact factor: 3.553

3.  Antibiotic penetration into lung tissues.

Authors:  D Honeybourne
Journal:  Thorax       Date:  1994-02       Impact factor: 9.139

Review 4.  Microbiology of airway disease in patients with cystic fibrosis.

Authors:  P H Gilligan
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

5.  Bacteriological effects of anti-Pseudomonas aeruginosa chemotherapy in cystic fibrosis.

Authors:  A Bauernfeind; G Emminger; G Hörl; S Ott; B Przyklenk; C Weisslein-Pfister
Journal:  Infection       Date:  1987       Impact factor: 3.553
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.